Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis

International Archives of Allergy and Immunology
Beatriz San RomanS Espuelas

Abstract

Two major drawbacks of current subcutaneous specific immunotherapy are the risk to induce severe anaphylactic reactions and the need of multiple injections of the allergen to reduce IgE-mediated hypersensitivity. The sustained release of allergens over time provided by poly(lactide-co-glycolide) microparticles (MP) could mimic the current therapeutic schedule and decrease their allergenicity. Moreover, MP could also co-deliver Th1 immunoadjuvants, such as CpG motifs. Ovalbumin (OVA)-sensitized BALB/c mice were treated intradermally with OVA or OVA plus CpG containing MP. OVA-specific IgG1 and IgG2a as well as IgE total levels and cytokine production were assessed throughout the experiment. The protection exerted by the MP against allergen challenge was estimated with body temperature changes, mortality and other symptoms. Microparticulated treatments, irrespective of the presence of CpG motifs, elicited a lower IgE/IgG2a ratio than those induced by the allergen in solution (free or with adjuvants). However, after induction of the anaphylactic shock, only mice treated with MP co-encapsulating OVA plus CpG showed a significant lower decrease in body temperature and were totally protected from death. Mice that were injected with O...Continue Reading

Citations

Mar 5, 2011·Current Opinion in Otolaryngology & Head and Neck Surgery·William R Reisacher, Dara Liotta
May 3, 2014·The Journal of Clinical Investigation·Corinne A Keet, Robert A Wood
Sep 15, 2015·Expert Opinion on Drug Delivery·Małgorzata Anna MarćCarlos Gamazo
Oct 22, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Takechiyo YamadaShigeharu Fujieda
Feb 22, 2011·International Immunopharmacology·Ravi Shankar PandeyVinod Kumar Dixit
Oct 8, 2014·Immunotherapy·Carlos GamazoJuan M Irache
Mar 18, 2017·Immunotherapy·Shokrollah FarrokhiNima Rezaei
Jan 15, 2013·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Ji-Hyeon ShinSoo Whan Kim
Jun 20, 2018·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Jeppe Madura Larsen, Katrine Lindholm Bøgh
Apr 29, 2020·Expert Review of Clinical Immunology·Mario Di GioacchinoLuca Di Giampaolo
Dec 29, 2020·Frontiers in Immunology·Christopher W M LinkRudolf A Manz
Apr 18, 2021·Immunology and Allergy Clinics of North America·Sultan Albuhairi, Rima Rachid
Jun 4, 2011·Current Opinion in Otolaryngology & Head and Neck Surgery

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.